Guobang Pharma Ltd. (605507.SS)

CNY 20.45

(0.34%)

Gross Profit Summary of Guobang Pharma Ltd.

  • Guobang Pharma Ltd.'s latest annual gross profit in 2023 was 1.2 Billion CNY , down -20.54% from previous year.
  • Guobang Pharma Ltd.'s latest quarterly gross profit in 2024 Q3 was 386.89 Million CNY , up 5.28% from previous quarter.
  • Guobang Pharma Ltd. reported a annual gross profit of 1.57 Billion CNY in annual gross profit 2022, up 16.08% from previous year.
  • Guobang Pharma Ltd. reported a annual gross profit of 1.35 Billion CNY in annual gross profit 2021, down -6.42% from previous year.
  • Guobang Pharma Ltd. reported a quarterly gross profit of 386.89 Million CNY for 2024 Q3, up 5.28% from previous quarter.
  • Guobang Pharma Ltd. reported a quarterly gross profit of 367.5 Million CNY for 2024 Q2, up 0.07% from previous quarter.

Annual Gross Profit Chart of Guobang Pharma Ltd. (2023 - 2017)

Historical Annual Gross Profit of Guobang Pharma Ltd. (2023 - 2017)

Year Gross Profit Gross Profit Growth
2023 1.2 Billion CNY -20.54%
2022 1.57 Billion CNY 16.08%
2021 1.35 Billion CNY -6.42%
2020 1.45 Billion CNY 47.12%
2019 986.19 Million CNY 1.18%
2018 974.68 Million CNY 15.9%
2017 841 Million CNY 0.0%

Peer Gross Profit Comparison of Guobang Pharma Ltd.

Name Gross Profit Gross Profit Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 7.74 Billion CNY 84.392%
Yabao Pharmaceutical Group Co., Ltd 1.66 Billion CNY 27.362%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 13.54 Billion CNY 91.076%
Harbin Pharmaceutical Group Co., Ltd. 3.76 Billion CNY 67.909%
Tasly Pharmaceutical Group Co., Ltd 5.66 Billion CNY 78.643%
Zhejiang Medicine Co., Ltd. 2.52 Billion CNY 52.111%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 3.59 Billion CNY 66.328%
Lionco Pharmaceutical Group Co.,Ltd. 86.95 Million CNY -1290.193%
Humanwell Healthcare (Group) Co.,Ltd. 10.65 Billion CNY 88.654%
Ginwa Enterprise (Group) Inc. 431.65 Million CNY -180.052%
Joincare Pharmaceutical Group Industry Co.,Ltd. 9.79 Billion CNY 87.659%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 361.03 Million CNY -234.826%
China Animal Husbandry Industry Co., Ltd. 1.06 Billion CNY -13.131%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 765.77 Million CNY -57.859%
Zhejiang Huahai Pharmaceutical Co., Ltd. 4.83 Billion CNY 75.003%
Shanghai Haoyuan Chemexpress Co., Ltd. 759.03 Million CNY -59.262%
Ningbo Menovo Pharmaceutical Co., Ltd. 342.7 Million CNY -252.737%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 2.07 Billion CNY 41.88%
Chongqing Taiji Industry(Group) Co.,Ltd 7.13 Billion CNY 83.063%
HPGC Renmintongtai Pharmaceutical Corporation 986.11 Million CNY -22.587%
Nanjing Well Pharmaceutical Group Co.,Ltd. 312.86 Million CNY -286.375%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 1.65 Billion CNY 26.965%
Henan Lingrui Pharmaceutical Co., Ltd. 2.42 Billion CNY 50.193%
Shenzhen Chipscreen Biosciences Co., Ltd. 433.54 Million CNY -178.828%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.84 Billion CNY 34.379%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 3.61 Billion CNY 66.537%
Zhongzhu Healthcare Holding Co.,Ltd -114.92 Million CNY 1151.84%
Beijing Tongrentang Co., Ltd 8.3 Billion CNY 85.443%
KPC Pharmaceuticals, Inc. 3.33 Billion CNY 63.752%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 735.98 Million CNY -64.248%
North China Pharmaceutical Company Ltd. 3.21 Billion CNY 62.379%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 5.61 Billion CNY 78.472%
Tibet Weixinkang Medicine Co., Ltd. 672.1 Million CNY -79.861%
China National Medicines Corporation Ltd. 3.85 Billion CNY 68.618%
Zhejiang Hisun Pharmaceutical Co., Ltd. 4.18 Billion CNY 71.11%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 1.32 Billion CNY 8.925%
ChengDu ShengNuo Biotec Co.,Ltd. 267.6 Million CNY -351.726%
Dali Pharmaceuticalco.,Ltd 36.29 Million CNY -3230.449%
Changchun BCHT Biotechnology Co. 1.6 Billion CNY 24.508%
Zhejiang Shengda Bio-Pharm Co., Ltd. 74.18 Million CNY -1529.519%
Shanghai Jiaoda Onlly Co.,Ltd 62.19 Million CNY -1843.602%
Jiang Zhong Pharmaceutical Co.,Ltd 2.74 Billion CNY 56.007%
Mayinglong Pharmaceutical Group Co., LTD. 1.3 Billion CNY 7.528%
Cisen Pharmaceutical Co., Ltd. 2.54 Billion CNY 52.588%
Hunan Warrant Pharmaceutical Co.,Ltd 928.23 Million CNY -30.231%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 19.8 Billion CNY 93.896%
Jianmin Pharmaceutical Group Co.,Ltd. 1.88 Billion CNY 35.75%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.1 Billion CNY -9.27%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.9 Billion CNY 36.475%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 183.75 Million CNY -557.876%
Kangmei Pharmaceutical Co., Ltd. 715.07 Million CNY -69.052%
Shandong Buchang Pharmaceuticals Co., Ltd. 8.7 Billion CNY 86.11%
Zhejiang Starry Pharmaceutical Co.,Ltd. 464.77 Million CNY -160.091%
Henan Taloph Pharmaceutical Stock Co.,Ltd 538.56 Million CNY -124.458%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.74 Billion CNY 30.843%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 659.13 Million CNY -83.398%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 528.34 Million CNY -128.797%
Shanghai Shyndec Pharmaceutical Co., Ltd. 4.39 Billion CNY 72.49%
Shanghai Yizhong Pharmaceutical Co., Ltd. 336.2 Million CNY -259.561%
Tibet Rhodiola Pharmaceutical Holding Co. 2.94 Billion CNY 58.898%
Sichuan Huiyu Pharmaceutical Co., Ltd. 787.59 Million CNY -53.486%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 431.02 Million CNY -180.456%
CanSino Biologics Inc. -876.01 Million CNY 237.993%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 1.04 Billion CNY -15.79%
Shandong Lukang Pharmaceutical Co.,Ltd. 1.46 Billion CNY 17.246%